Drugs
Pharmacy Reimagined For years, hospital CEOs and CFOs have considered their pharmacies [...]
More Than Medicine The demand for behavioral healthcare has surged since 2020—and across [...]
Supply & Demand for GLP-1s:
What’s in Store?
How pharmacies, members & patients can think about accessibility & [...]
Overcoming Complex Class-of-Trade Pricing Shopping under the restrictions of class of trade could go [...]
Formulating Formularies for High-priced Pharmaceuticals St. Luke’s has been on a mission to streamline and [...]
Riding the Wave of Progress Staying on top of the evolution in oncology & biologics [...]
Preventing Drug Diversion Keeping patients safe from harm while reducing [...]
All About the Drug Supply Chain Security Act Phase two is underway & bringing changes with [...]
Tackling Pharmaceutical Waste New rules from the Centers for Medicare & Medicaid Services [...]
On the Way to Market Most new pharmaceuticals are submitted through either a New Drug [...]
Navigating 340B with a Third Party Administrator When a covered entity is looking to contract with a [...]
340B Programs: When the Price Just Isn’t Right Section 340B of the Public Health Service Act is essentially [...]
PBMs: A Dose of Savings What is the true value of a PBM? Pharmaceutical contracting [...]
A Vital Balancing Act There’s never been a more exciting time to work in [...]
Mitigating Drug Supply Disruptions Drug supply threats aren’t new. But the COVID-19 pandemic has [...]
Facilitating an Agile & Resilient Supply Chain: From the Desk of the CEO Pandemic-related supply chain disruption, inflation, Russia’s war in Ukraine, ongoing [...]
